ID: ALA4115385

Max Phase: Preclinical

Molecular Formula: C15H19N3O4S

Molecular Weight: 337.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nn(C)c(C)c1NS(=O)(=O)c1ccc(C2OCCO2)cc1

Standard InChI:  InChI=1S/C15H19N3O4S/c1-10-14(11(2)18(3)16-10)17-23(19,20)13-6-4-12(5-7-13)15-21-8-9-22-15/h4-7,15,17H,8-9H2,1-3H3

Standard InChI Key:  KRNAIUOXHKDJNP-UHFFFAOYSA-N

Associated Targets(non-human)

Glycylpeptide N-tetradecanoyltransferase 506 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 337.40Molecular Weight (Monoisotopic): 337.1096AlogP: 1.88#Rotatable Bonds: 4
Polar Surface Area: 82.45Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.69CX Basic pKa: 2.90CX LogP: 1.20CX LogD: 0.61
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.92Np Likeness Score: -1.70

References

1.  (2015)  N-myristoyl transferase inhibitors, 

Source

Source(1):